Used in pharmaceutical synthesis as a chiral building block for active pharmaceutical ingredients (APIs), particularly in the development of central nervous system agents and kinase inhibitors. Its trifluoromethyl-substituted pyridine structure enhances metabolic stability and bioavailability in drug candidates. Commonly employed in asymmetric synthesis due to the chiral amine functionality, enabling selective formation of target molecules in medicinal chemistry. Also utilized in agrochemicals for the design of bioactive molecules with improved environmental stability.